Topics

21st Annual BIO CEO & Investor Conference Programming Announced

16:09 EST 28 Nov 2018 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Program lineup covers policy, investment, innovation and patient access The Biotechnology Innovation Organization (BIO) today announced preliminary programing for the upcoming BIO CEO & Investor Conference ...

Other Sources for this Article

Theresa Brady
202-962-9235
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech

NEXT ARTICLE

More From BioPortfolio on "21st Annual BIO CEO & Investor Conference Programming Announced"

Quick Search

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...